WARPTECHNEWS · LAB

Home AI Business Tech Archive

Storia: Guardant Bleeds After Losing A Costly Patent Dispute — Warptech Lab News

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 4 fonti

Guardant Bleeds After Losing A Costly Patent Dispute

Guardant Health stock tumbled Monday after losing a patent battle against privately held TwinStrand Biosciences.

Raccontata da

morningstar.com

timesofindia.indiatimes.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

investors.comStai leggendo6 g fa

Guardant Bleeds After Losing A Costly Patent Dispute

Guardant Health stock tumbled Monday after losing a patent battle against privately held TwinStrand Biosciences.

Timeline cronologica

lunedì 24 agosto 2026·morningstar.com
TwinStrand Biosciences Announces Final Judgment in Patent Infringement Suit Against Guardant Health, Awarding TwinStrand and the University…
TwinStrand Biosciences Announces Final Judgment in Patent Infringement Suit Against Guardant Health, Awarding TwinStrand and the University of Washington More Than $245.2 Million…
lunedì 24 agosto 2026·investors.com
Guardant Bleeds After Losing A Costly Patent Dispute
Guardant Health stock tumbled Monday after losing a patent battle against privately held TwinStrand Biosciences.

6 g fa

Guardant Health Hit With Royalties Over Duplex Sequencing Tech - Guardant Health (NASDAQ:GH)

Guardant Health must pay TwinStrand Biosciences and the University of Washington over $245 million after a court finalized a patent dispute.

Leggi questa versione → originale

morningstar.com6 g fa

Guardant Health to Appeal Federal District Court Judgment

Guardant Health to Appeal Federal District Court Judgment

Leggi questa versione → originale

timesofindia.indiatimes.com4 g fa

US Court to pharma giant Guardant Health: You willfully infringed patents for cancer-testing; asked to pay…

A federal judge has finalized a judgment ordering pharma giant Guardant Health to pay more than $245 million to Seattle-based biotech startup TwinStrand Biosciences and the University of Washington for willfully…

Leggi questa versione → originale

lunedì 24 agosto 2026·

benzinga.com

Guardant Health Hit With Royalties Over Duplex Sequencing Tech - Guardant Health (NASDAQ:GH)

Guardant Health must pay TwinStrand Biosciences and the University of Washington over $245 million after a court finalized a patent dispute.

lunedì 24 agosto 2026·

morningstar.com

Guardant Health to Appeal Federal District Court Judgment

Guardant Health to Appeal Federal District Court Judgment

mercoledì 26 agosto 2026·

timesofindia.indiatimes.com

US Court to pharma giant Guardant Health: You willfully infringed patents for cancer-testing; asked to pay $245 million to University of…

A federal judge has finalized a judgment ordering pharma giant Guardant Health to pay more than $245 million to Seattle-based biotech startup TwinStrand Biosciences and the…